Vanguard Personalized Indexing Management, LLC Bridge Bio Pharma, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.09 Billion
- Q3 2024
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 12,125 shares of BBIO stock, worth $300,578. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,125
Previous 10,202
18.85%
Holding current value
$300,578
Previous $258,000
19.38%
% of portfolio
0.01%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BBIO
# of Institutions
305Shares Held
179MCall Options Held
8.68MPut Options Held
2.75M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$626 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$623 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$352 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$309 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$150 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.68B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...